HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.

HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B57 that is distinct from HLA-B58:01.

HLA-B*57 is strongly associated with immune control of HIV and delayed AIDS progression. The closely related, but less protective, HLA-B*58:01 presents similar epitopes, but HLA-B*58:01(+) individuals do not generate CD8(+) T cells targeting the KF11-Gag epitope, which has been linked to low viremia...

Full description

Bibliographic Details
Main Authors:	Kløverpris, H, Stryhn, A, Harndahl, M, Payne, R, Towers, G, Chen, F, Riddell, L, Walker, B, Ndung'u, T, Leslie, A, Buus, S, Goulder, P
Format:	Journal article
Language:	English
Published:	2013

Similar Items

HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
by: Kloverpris, H, et al.
Published: (2012)

HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.
by: Frahm, N, et al.
Published: (2005)

Major TCR repertoire perturbation by immunodominant HLA-B*44:03-restricted CMV-specific T cells
by: Attaf, M, et al.
Published: (2018)

HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides.
by: Erup Larsen, M, et al.
Published: (2011)

Viral Evasion of Immune Control Mediated by Coexpression of HLA-B*27:05 and HLA-B*57:01
by: Brener, J, et al.
Published: (2013)

Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.
by: Mkhwanazi, N, et al.
Published: (2010)

HLA-B*4201-restricted inter- and intra-protein-specific differences in anti-HIV CD8(+) T-cell epitope efficacy
by: Kloverpris, H, et al.
Published: (2010)

HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
by: Matthews, P, et al.
Published: (2011)

HIV control through a single nucleotide on the HLA-B locus.
by: Kløverpris, H, et al.
Published: (2012)

HLA-A*68:02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective.
by: Kløverpris, H, et al.
Published: (2013)

HLA-A*68: 02-restricted Gag-specific cytotoxic T lymphocyte responses can drive selection pressure on HIV but are subdominant and ineffective
by: Kløverpris, H, et al.
Published: (2013)

Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.
by: Payne, R, et al.
Published: (2014)

Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.
by: Maenaka, K, et al.
Published: (2000)

Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
by: Matthews, P, et al.
Published: (2012)

HLA-B*57 versus HLA-B*81 in HIV-1 infection: Slow and steady wins the race?
by: Prentice, H, et al.
Published: (2013)

Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
by: Crawford, H, et al.
Published: (2009)

HIV control through a single nucleotide on the HLA-I locus
by: Kloverpris, H, et al.
Published: (2012)

Revisiting the Influence of HLA-type, Frequency, HLA-supertype and Homozygosity on the Immune Control of HIV
by: Leslie, A, et al.
Published: (2008)

Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccines.
by: Karlsson, I, et al.
Published: (2012)

Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev.
by: Makadzange, A, et al.
Published: (2006)

Allopurinol-Induced Stevens–Johnson Syndrome in Javanese Men With Positive HLA-B*58:01
by: Ferdiana, Astri, et al.
Published: (2022)

Allopurinol-Induced Stevens–Johnson Syndrome in Javanese Men With Positive HLA‐B*58:01
by: Ferdiana, Astri, et al.
Published: (2022)

Allopurinol-Induced Stevens–Johnson Syndrome in Javanese Men With Positive HLA-B*58:01
by: Ferdiana, Astri, et al.
Published: (2022)

HLA-B27
by: Bowness, P
Published: (2015)

Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
by: Brener, J, et al.
Published: (2018)

Residue Cys-67 of HLA-B27 contributes to antigen presentation and T cell recognition of HLA-B27 restricted T cell epitopes.
by: Appel, H, et al.
Published: (2004)

Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.
by: Goulder, P, et al.
Published: (1997)

Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
by: Payne, R, et al.
Published: (2010)

Chapter 1 HLA-Mediated Control of HIV and HIV Adaptation to HLA
by: Payne, R, et al.
Published: (2009)

Lower viral loads and slower CD4 decline in MRKAd5 HIV-1 vaccinees expressing disease-susceptible HLA-B*58:02
by: Leitman, E, et al.
Published: (2016)

Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.
by: Aidoo, M, et al.
Published: (2000)

Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
by: Altfeld, M, et al.
Published: (2000)

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
by: Goulder, P, et al.
Published: (1997)

HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
by: Goulder, P, et al.
Published: (2000)

Differential immunodominance hierarchy of CD8+ T cell responses in HLA-B*27:05 and B*27:02-mediated control of HIV-1 infection.
by: Adland, E, et al.
Published: (2017)

Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.
by: Hill, A, et al.
Published: (1995)

Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
by: Wright, J, et al.
Published: (2012)

HLA class I typing by PCR: HLA-B27 and an African B27 subtype.
by: Hill, A, et al.
Published: (1991)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
by: Wong-Baeza, I, et al.
Published: (2011)

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
by: Altfeld, M, et al.
Published: (2003)